Lv3
248 积分 2023-07-24 加入
Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma
12天前
已完结
Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy
12天前
已完结
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
12天前
已完结
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
13天前
已完结
Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model
1个月前
已完结
Hybrid Cellular Nanovesicles Block PD‐L1 Signal and Repolarize M2 Macrophages for Cancer Immunotherapy
2个月前
已完结
Surface-Engineering of Red Blood Cells as Artificial Antigen Presenting Cells Promising for Cancer Immunotherapy
2个月前
已完结
Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy
2个月前
已完结
IMPA1-derived inositol maintains stemness in castration-resistant prostate cancer via IMPDH2 activation
3个月前
已完结
Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
3个月前
已完结
皖公网安备34019202002308
